DT Investment Partners LLC Makes New $217,000 Investment in The Chemours Company (NYSE:CC)

DT Investment Partners LLC purchased a new stake in shares of The Chemours Company (NYSE:CCFree Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm purchased 7,000 shares of the specialty chemicals company’s stock, valued at approximately $217,000.

A number of other hedge funds also recently modified their holdings of the business. BlackRock Inc. raised its holdings in Chemours by 29.0% during the 1st quarter. BlackRock Inc. now owns 18,075,740 shares of the specialty chemicals company’s stock worth $569,023,000 after purchasing an additional 4,060,250 shares during the last quarter. Vanguard Group Inc. raised its stake in Chemours by 5.5% during the third quarter. Vanguard Group Inc. now owns 17,741,300 shares of the specialty chemicals company’s stock worth $437,324,000 after buying an additional 932,063 shares during the last quarter. Bank of New York Mellon Corp lifted its holdings in Chemours by 11.0% in the third quarter. Bank of New York Mellon Corp now owns 6,196,063 shares of the specialty chemicals company’s stock valued at $173,800,000 after buying an additional 612,071 shares during the period. State Street Corp boosted its position in Chemours by 5.8% during the first quarter. State Street Corp now owns 4,618,424 shares of the specialty chemicals company’s stock valued at $145,388,000 after acquiring an additional 254,243 shares during the last quarter. Finally, JPMorgan Chase & Co. grew its holdings in Chemours by 9.7% during the 1st quarter. JPMorgan Chase & Co. now owns 3,164,475 shares of the specialty chemicals company’s stock worth $94,745,000 after acquiring an additional 279,414 shares during the period. Institutional investors and hedge funds own 76.26% of the company’s stock.

Analysts Set New Price Targets

CC has been the topic of a number of recent analyst reports. BMO Capital Markets raised Chemours from an “underperform” rating to an “outperform” rating and boosted their price objective for the company from $19.00 to $34.00 in a research note on Tuesday, April 9th. UBS Group lifted their target price on Chemours from $21.00 to $28.00 and gave the stock a “neutral” rating in a report on Tuesday, April 2nd. Finally, Barclays cut their price target on Chemours from $32.00 to $30.00 and set an “equal weight” rating on the stock in a report on Tuesday, April 2nd. Seven equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, Chemours has a consensus rating of “Hold” and an average target price of $30.89.

Check Out Our Latest Analysis on CC

Chemours Stock Down 2.2 %

Shares of CC opened at $25.91 on Friday. The business’s fifty day moving average is $26.90 and its 200 day moving average is $27.80. The company has a current ratio of 1.54, a quick ratio of 1.00 and a debt-to-equity ratio of 5.40. The Chemours Company has a 12-month low of $15.10 and a 12-month high of $39.05.

Chemours (NYSE:CCGet Free Report) last released its quarterly earnings data on Wednesday, March 27th. The specialty chemicals company reported $0.31 earnings per share for the quarter, beating analysts’ consensus estimates of $0.29 by $0.02. Chemours had a negative net margin of 3.80% and a positive return on equity of 51.73%. The firm had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.37 billion. On average, research analysts predict that The Chemours Company will post 2.23 EPS for the current fiscal year.

Chemours Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 15th. Stockholders of record on Monday, February 26th were paid a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 3.86%. The ex-dividend date was Friday, February 23rd. Chemours’s dividend payout ratio (DPR) is presently -64.52%.

About Chemours

(Free Report)

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.

Featured Articles

Institutional Ownership by Quarter for Chemours (NYSE:CC)

Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.